Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Open in Screener

ADPT

Adaptive Biotechnologies Corp

May 08 • 09:38AM ET

3.63

Dollar change +0.52
Percentage change 16.72	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: ARKG VTI VB IWM VBK VXF IBB IWO SCHA VTWO

Index	RUT	P/E	-	EPS (ttm)	-1.48	Insider Own	4.54%	Shs Outstand	145.08M	Perf Week	30.11%
Market Cap	534.95M	Forward P/E	-	EPS next Y	-1.11	Insider Trans	-2.64%	Shs Float	140.68M	Perf Month	23.89%
Income	-215.06M	PEG	-	EPS next Q	-0.33	Inst Own	92.20%	Short Float	7.11%	Perf Quarter	1.68%
Sales	174.50M	P/S	3.07	EPS this Y	15.37%	Inst Trans	-3.04%	Short Ratio	5.78	Perf Half Y	-24.38%
Book/sh	1.87	P/B	1.95	EPS next Y	15.85%	ROA	-30.47%	Short Interest	10.01M	Perf Year	-45.00%
Cash/sh	2.10	P/C	1.73	EPS next 5Y	21.60%	ROE	-61.54%	52W Range	2.28 - 9.08	Perf YTD	-25.92%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-32.91%	ROI	-59.44%	52W High	-60.02%	Beta	1.29
Dividend TTM	-	Quick Ratio	4.35	Sales past 5Y	27.46%	Gross Margin	47.19%	52W Low	59.21%	ATR (14)	0.26
Dividend Ex-Date	-	Current Ratio	4.51	EPS Y/Y TTM	-10.98%	Oper. Margin	-118.40%	RSI (14)	67.17	Volatility	8.34% 8.82%
Employees	709	Debt/Eq	0.35	Sales Y/Y TTM	-5.33%	Profit Margin	-123.24%	Recom	1.50	Target Price	6.67
Option/Short	Yes / Yes	LT Debt/Eq	0.32	EPS Q/Q	18.93%	Payout	-	Rel Volume	2.11	Prev Close	3.11
Sales Surprise	7.98%	EPS Surprise	4.51%	Sales Q/Q	11.23%	Earnings	May 07 AMC	Avg Volume	1.73M	Price	3.63
SMA20	33.30%	SMA50	17.00%	SMA200	-20.67%	Trades		Volume	253,306	Change	16.72%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-05-23	Resumed	JP Morgan	Overweight	$15
Jan-05-23	Initiated	Scotiabank	Sector Outperform	$15
Dec-21-22	Upgrade	Piper Sandler	Neutral → Overweight	$7.50 → $14
Aug-25-22	Initiated	Credit Suisse	Underperform	$8
Jun-03-22	Initiated	Piper Sandler	Neutral	$7.50
Feb-16-22	Reiterated	JP Morgan	Overweight	$75 → $50
Feb-16-22	Reiterated	Goldman	Neutral	$54 → $21
Feb-16-22	Reiterated	BTIG Research	Buy	$35 → $30
Feb-16-22	Reiterated	BofA Securities	Buy	$40 → $32
Oct-15-21	Resumed	Cowen	Outperform
Mar-03-21	Downgrade	Goldman	Buy → Neutral	$74 → $63
Oct-08-20	Resumed	BTIG Research	Buy	$60
Sep-09-20	Initiated	Morgan Stanley	Equal-Weight	$42
Jun-03-20	Initiated	Goldman	Buy	$60
Jul-23-19	Initiated	BTIG Research	Buy	$46
Jul-22-19	Initiated	William Blair	Outperform
Jul-22-19	Initiated	Guggenheim	Buy	$47
Jul-22-19	Initiated	Goldman	Neutral	$32
Jul-22-19	Initiated	Cowen	Outperform
Jul-22-19	Initiated	BofA/Merrill	Buy	$45

Show Previous Ratings

Today 03:54AM	Adaptive Biotechnologies Corp (ADPT) Q1 2024 Earnings Call Transcript Highlights: Strategic ... (GuruFocus.com) +16.72%
May-07-24 07:30PM	Compared to Estimates, Adaptive Biotechnologies (ADPT) Q1 Earnings: A Look at Key Metrics (Zacks)
05:47PM	Adaptive Biotechnologies Q1 2024 Earnings: Revenue Beats Estimates Amidst Challenges (GuruFocus.com)
05:40PM	Adaptive Biotechnologies (ADPT) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:37PM	Adaptive Biotechnologies: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Loading…
04:05PM	Adaptive Biotechnologies Reports First Quarter 2024 Financial Results (GlobeNewswire)
Apr-26-24 10:02AM	PhaseV and Quanticate partner to help sponsors run more adaptive trials (Clinical Trials Arena)
Apr-17-24 04:05PM	Adaptive Biotechnologies to Report First Quarter 2024 Financial Results on May 7, 2024 (GlobeNewswire) -11.27%
Apr-02-24 04:05PM	Adaptive Biotechnologies Provides Strategic Review Update and Announces Preliminary First Quarter 2024 Revenue (GlobeNewswire)
Mar-27-24 04:30PM	The 7 Best Penny Stocks to Buy in Q2 2024 (InvestorPlace)
08:30AM	Adaptive Biotechnologies to Hold a Business Update Conference Call and Webcast on April 2, 2024 (GlobeNewswire)
Mar-11-24 12:01AM	Team behind popular Falcon AI models unveils new startup with $20 million in funding aimed at helping companies tailor LLMs for business (Fortune)
Feb-22-24 04:05PM	Adaptive Biotechnologies to Present at the TD Cowen 44th Annual Healthcare Conference (GlobeNewswire)
Feb-15-24 10:09AM	Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q4 2023 Earnings Call Transcript (Insider Monkey)
06:37AM	Q4 2023 Adaptive Biotechnologies Corp Earnings Call (Thomson Reuters StreetEvents)
05:16PM	Loading…
Feb-14-24 05:16PM	Adaptive Biotechnologies Corp (ADPT) Faces Revenue Decline Amid Growth in MRD Segment (GuruFocus.com) +8.84%
04:43PM	Adaptive Biotechnologies: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Feb-13-24 02:23AM	Here's Why Adaptive Biotechnologies Corporation (ADPT) Declined in Q4 (Insider Monkey) -7.65%
Feb-12-24 09:16AM	Exploring Analyst Estimates for Adaptive Biotechnologies (ADPT) Q4 Earnings, Beyond Revenue and EPS (Zacks)
Jan-29-24 04:05PM	Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2023 Financial Results on February 14, 2024 (GlobeNewswire)
Dec-27-23 04:05PM	Adaptive Biotechnologies to Present at the 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-12-23 05:50AM	Cathie Wood Is Loading Up on These 3 Small-Cap Stocks: Should You? (Motley Fool)
Dec-11-23 03:30PM	16 Best Penny Stocks To Buy For 2024 (Insider Monkey)
Dec-09-23 08:30AM	Adaptive Biotechnologies Announces New Data Highlighting the Clinical Relevance of MRD Testing with clonoSEQ in Patients with Blood Cancers at the 65th ASH Annual Meeting (GlobeNewswire)
Dec-05-23 07:30AM	Adaptive Biotechnologies and Collaborators to Present More than 30 Abstracts Demonstrating the Actionability of clonoSEQ MRD Testing in Blood Cancer Patient Care and Drug Development at the 65th ASH Annual Meeting (GlobeNewswire) -7.14%
Nov-10-23 01:52PM	Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q3 2023 Earnings Call Transcript (Insider Monkey) -18.18%
Nov-09-23 04:17PM	Adaptive Biotechnologies: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Adaptive Biotechnologies Reports Third Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
Nov-07-23 07:30AM	Adaptive Biotechnologies Announces New Translational Collaboration to Measure Minimal Residual Disease with clonoSEQ Assay Across BeiGene's Lymphoid Malignancy Pipeline (GlobeNewswire)
04:05PM	Loading…
Nov-02-23 04:05PM	Adaptive Biotechnologies to Report Third Quarter Financial Results on November 9, 2023 (GlobeNewswire) +9.46%
Oct-26-23 10:02AM	Adaptive Biotechnologies (ADPT) May Report Negative Earnings: Know the Trend Ahead of Q3 Release (Zacks)
Oct-17-23 07:57AM	Prothena (PRTA) Soars 18.7%: Is Further Upside Left in the Stock? (Zacks)
Sep-27-23 05:14AM	Strength Seen in Adaptive Biotechnologies (ADPT): Can Its 9.5% Jump Turn into More Strength? (Zacks)
Sep-13-23 07:30AM	Adaptive Announces Launch of Epic Integration for clonoSEQ® (GlobeNewswire)
Aug-30-23 04:30PM	Adaptive Biotechnologies to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference (GlobeNewswire)
Aug-28-23 11:53PM	3 Up-and-Coming Biotech Stocks to Put on Your Must-Buy List (InvestorPlace)
Aug-24-23 10:29AM	Cathie Wood Just Sold Shopify -- and Bought These 7 Potentially Explosive Growth Stocks (Motley Fool) -6.62%
Aug-02-23 05:35PM	Adaptive Biotechnologies (ADPT) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:30PM	Adaptive Biotechnologies: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Adaptive Biotechnologies Reports Second Quarter 2023 Financial Results (GlobeNewswire)
Jul-29-23 12:12AM	Is it Still Worthy to Invest in Adaptive Biotechnologies (ADPT)? (Insider Monkey)
Jul-19-23 08:52AM	Viking Globals Performance, AUM, and Long-Term Stock Picks (Insider Monkey)
Jul-10-23 04:05PM	Adaptive Biotechnologies to Report Second Quarter Financial Results on August 2, 2023 (GlobeNewswire) +8.28%
Jun-24-23 03:19PM	11 Best Medical Stocks Under $10 (Insider Monkey)
Jun-16-23 05:02PM	Why Shares of Adaptive Biotechnologies Jumped This Week (Motley Fool)
Jun-02-23 10:15AM	Cathie Wood Goes Bargain-Hunting: 3 Stocks She Just Bought (Motley Fool) +5.82%
07:34AM	Adaptive Biotechnologies Highlights New Data at ASCO 2023 and EHA 2023 Underscoring the clonoSEQ® Assays Impact as a Standard for Minimal Residual Disease Assessment in Patients with Hematologic Cancer (GlobeNewswire)
May-29-23 08:08AM	Strong week for Adaptive Biotechnologies (NASDAQ:ADPT) shareholders doesn't alleviate pain of three-year loss (Simply Wall St.)
May-26-23 09:45AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool)
May-24-23 04:05PM	Adaptive Biotechnologies to Participate in Upcoming June Investor Conferences (GlobeNewswire) +6.42%
May-23-23 09:54AM	Too Cheap to Ignore: Cathie Wood Snaps Up These 2 Stocks Under $10 (TipRanks)
May-15-23 07:50AM	3 Personalized Medicine Stocks to Buy for Long-Time Returns (InvestorPlace)
May-12-23 08:00AM	Adaptive Biotechnologies to Participate in the 2023 RBC Capital Markets Global Healthcare Conference (GlobeNewswire)
May-09-23 07:30AM	Adaptive Biotechnologies Announces FDA Acceptance of Genentechs Investigational New Drug Application for the First Neoantigen-Directed T-Cell Therapy Product in Oncology (GlobeNewswire) +6.21%
May-04-23 09:13AM	Q1 2023 Adaptive Biotechnologies Corp Earnings Call (Thomson Reuters StreetEvents) -14.27%
May-03-23 05:25PM	Adaptive Biotechnologies (ADPT) Reports Q1 Loss, Tops Revenue Estimates (Zacks) +6.99%
04:05PM	Adaptive Biotechnologies Reports First Quarter 2023 Financial Results (GlobeNewswire)
Apr-27-23 10:02AM	Analysts Estimate Blueprint Medicines (BPMC) to Report a Decline in Earnings: What to Look Out for (Zacks)
Apr-26-23 10:02AM	Adaptive Biotechnologies (ADPT) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
Apr-25-23 04:05PM	Adaptive Biotechnologies to Participate in the BofA Securities 2023 Healthcare Conference (GlobeNewswire) -9.82%
Apr-24-23 09:40AM	Is Adaptive Biotechnologies (ADPT) Stock Outpacing Its Medical Peers This Year? (Zacks)
Apr-18-23 12:10PM	Investors Still Waiting For A Pull Back In Adaptive Biotechnologies Corporation (NASDAQ:ADPT) (Simply Wall St.)
Apr-12-23 07:30AM	Adaptive Biotechnologies Announces Translational Collaboration with Takeda to Measure Minimal Residual Disease with Its clonoSEQ® Assay Across Its Hematologic Malignancy Pipeline (GlobeNewswire)
Apr-06-23 04:05PM	Adaptive Biotechnologies to Report First Quarter Financial Results on May 3, 2023 (GlobeNewswire)
Mar-29-23 04:20PM	11 Most Promising Gene Editing Stocks According to Analysts (Insider Monkey)
Mar-27-23 09:40AM	Is Fulgent Genetics (FLGT) Stock Outpacing Its Medical Peers This Year? (Zacks)
Mar-16-23 11:41AM	Bellicum (BLCM) Down on Ending Development of CAR-T Candidates (Zacks)
Mar-10-23 10:42AM	Neoleukin (NLTX) Up 36% on Initiating Another Restructuring Plan (Zacks)
10:26AM	AstraZeneca (AZN) Posts Positive Data From Lung Cancer Studies (Zacks)
Mar-09-23 09:55AM	How Much Upside is Left in Adaptive Biotechnologies (ADPT)? Wall Street Analysts Think 49.94% (Zacks) -7.54%
09:40AM	Is Fulgent Genetics (FLGT) Outperforming Other Medical Stocks This Year? (Zacks)
Feb-28-23 11:11AM	Perrigo (PRGO) Beats Q4 Earnings Estimates, Lags on Sales (Zacks)
Feb-27-23 04:05PM	Adaptive Biotechnologies to Participate in the 43rd Annual Cowen Healthcare Conference (GlobeNewswire)
Feb-24-23 11:52AM	Karuna (KRTX) Reports Narrower-Than-Expected Loss in Q4 (Zacks)
Feb-21-23 09:55AM	Can Adaptive Biotechnologies (ADPT) Climb 45.58% to Reach the Level Wall Street Analysts Expect? (Zacks) -7.37%
09:40AM	Is Adaptive Biotechnologies (ADPT) Stock Outpacing Its Medical Peers This Year? (Zacks)
Feb-14-23 05:55PM	Adaptive Biotechnologies (ADPT) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
04:05PM	Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2022 Financial Results (GlobeNewswire)
Jan-30-23 07:21AM	Companies Like Adaptive Biotechnologies (NASDAQ:ADPT) Are In A Position To Invest In Growth (Simply Wall St.)
Jan-23-23 04:05PM	Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2022 Financial Results on February 14, 2023 (GlobeNewswire)
Jan-10-23 09:00AM	Capella Space Raises $60M in Growth Equity from the United States Innovative Technology Fund to Expand Satellite Imaging Capacity and Meet Rapidly Growing Customer Demand (PR Newswire)
Dec-27-22 04:05PM	Adaptive Biotechnologies to Present at the 41st Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-20-22 06:14AM	Adaptive Biotechnologies (NASDAQ:ADPT shareholders incur further losses as stock declines 17% this week, taking three-year losses to 76% (Simply Wall St.)
Dec-10-22 10:00AM	Adaptive Biotechnologies Highlights New Data Showcasing the Clinical Utility of clonoSEQ® MRD Testing in Patients with Blood Cancers at the 64th ASH Annual Meeting (GlobeNewswire)
Dec-05-22 07:30AM	Adaptive Biotechnologies and Collaborators to Present More than 30 Abstracts Demonstrating the Clinical Utility and Benefit of clonoSEQ® MRD Testing in Blood Cancer Patients at 2022 ASH Annual Meeting (GlobeNewswire) -7.92%
Dec-01-22 07:30AM	Adaptive Biotechnologies Announces Launch of clonoSEQ® to Assess Minimal Residual Disease (MRD) in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Using Circulating Tumor DNA (ctDNA) (GlobeNewswire)
Nov-21-22 04:05PM	Adaptive Biotechnologies to Participate in the Piper Sandler Healthcare Conference (GlobeNewswire)
07:30AM	New Survey Reveals the Majority of Myeloma Patients That Undergo Minimal Residual Disease (MRD) Testing Find a Clear Clinical or Emotional Benefit from Results (GlobeNewswire)
Nov-03-22 06:35PM	Adaptive Biotechnologies (ADPT) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
04:05PM	Adaptive Biotechnologies Reports Third Quarter 2022 Financial Results (GlobeNewswire)
Oct-11-22 08:05AM	Adaptive Announces Partnership with Epic to Increase Access to Minimal Residual Disease (MRD) Monitoring in Blood Cancers (GlobeNewswire)
Oct-05-22 04:05PM	Adaptive Biotechnologies to Report Third Quarter of 2022 Financial Results on November 3, 2022 (GlobeNewswire)
Sep-15-22 06:48AM	Institutional owners may consider drastic measures as Adaptive Biotechnologies Corporation's (NASDAQ:ADPT) recent US$104m drop adds to long-term losses (Simply Wall St.)
Sep-14-22 05:22PM	Adaptive Biotechnologies to receive up to $250M in financing deal (American City Business Journals)
Sep-12-22 08:30AM	Adaptive Biotechnologies Announces Non-Dilutive Royalty Financing with OrbiMed for Up to $250 Million (GlobeNewswire)
Sep-02-22 08:00AM	Adaptive Biotechnologies to Participate in the Morgan Stanley Global Healthcare Conference (GlobeNewswire)
Aug-14-22 11:13AM	3 Cathie Wood Stocks for the Future (Motley Fool)
Aug-04-22 12:00AM	Adaptive Biotechnologies Corporation (ADPT) Q2 2022 Earnings Call Transcript (Motley Fool) +14.86%
Aug-03-22 05:35PM	Adaptive Biotechnologies (ADPT) Reports Q2 Loss, Tops Revenue Estimates (Zacks)

Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson on September 8, 2009 and is headquartered in Seattle, WA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
NEUPERT PETER M	Director	Mar 12 '24	Option Exercise	0.84	15,000	12,600	169,296	Mar 13 05:55 PM
ROBINS CHAD M	CEO and Chairman	Mar 05 '24	Sale	3.43	48,673	167,007	2,576,701	Mar 06 07:40 PM
RUBINSTEIN JULIE	President	Mar 05 '24	Sale	3.47	39,070	135,764	472,754	Mar 06 07:41 PM
BENZENO SHARON	Chief Commercial Ofc Imm Med	Mar 05 '24	Sale	3.44	29,390	100,994	327,415	Mar 06 07:42 PM
PETERSON TYCHO	Chief Financial Officer	Mar 05 '24	Sale	3.44	15,456	53,169	531,553	Mar 06 07:40 PM
LO FRANCIS	Chief People Officer	Mar 05 '24	Sale	3.43	14,700	50,439	253,745	Mar 06 07:42 PM
Taylor Stacy L	SVP and General Counsel	Mar 05 '24	Sale	3.43	13,381	45,963	166,287	Mar 06 07:42 PM
BOBULSKY SUSAN	Chief Commercial Officer, MRD	Mar 05 '24	Sale	3.44	12,991	44,629	248,290	Mar 06 07:39 PM
PISKEL KYLE	Principal Accounting Officer	Mar 05 '24	Sale	3.43	7,727	26,504	123,318	Mar 06 07:43 PM
NEUPERT PETER M	Director	Dec 13 '23	Option Exercise	0.84	100,000	84,000	122,968	Dec 15 04:21 PM
PISKEL KYLE	Principal Accounting Officer	Nov 16 '23	Sale	4.13	259	1,070	87,305	Nov 20 05:30 PM
SOOD NITIN	Chief Commercial Officer, MRD	Aug 08 '23	Sale	6.54	10,550	68,997	214,808	Aug 08 04:53 PM
SOOD NITIN	Chief Commercial Officer, MRD	Aug 07 '23	Sale	6.78	5,652	38,321	225,358	Aug 08 04:53 PM
PETERSON TYCHO	Chief Financial Officer	Jun 20 '23	Option Exercise	7.30	134,961	985,215	534,180	Jun 21 05:32 PM
PETERSON TYCHO	Chief Financial Officer	Jun 20 '23	Sale	8.14	134,961	1,098,583	399,219	Jun 21 05:32 PM
PETERSON TYCHO	Chief Financial Officer	Jun 15 '23	Option Exercise	7.30	14,328	104,594	413,547	Jun 20 05:41 PM
PETERSON TYCHO	Chief Financial Officer	Jun 15 '23	Sale	8.53	70,000	597,100	399,219	Jun 20 05:41 PM
PETERSON TYCHO	Chief Financial Officer	Jun 02 '23	Sale	7.16	38,000	272,080	454,891	Jun 06 04:23 PM

Open in Screener

SDRL

Seadrill Ltd.

May 08 • 09:38AM ET

50.96

Dollar change -0.08
Percentage change -0.16	%

Energy • Oil & Gas Drilling • Bermuda • NYSE

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: IWM IWN DFAT VTWO DFSV DFAS DFAC VTWV DFUV RYLD

Index	RUT	P/E	12.70	EPS (ttm)	4.01	Insider Own	5.24%	Shs Outstand	74.05M	Perf Week	5.68%
Market Cap	3.76B	Forward P/E	8.10	EPS next Y	6.29	Insider Trans	0.00%	Shs Float	69.93M	Perf Month	-2.97%
Income	300.00M	PEG	-	EPS next Q	0.66	Inst Own	91.57%	Short Float	5.90%	Perf Quarter	18.87%
Sales	1.50B	P/S	2.50	EPS this Y	-36.44%	Inst Trans	-	Short Ratio	6.07	Perf Half Y	25.12%
Book/sh	40.28	P/B	1.27	EPS next Y	140.37%	ROA	8.55%	Short Interest	4.12M	Perf Year	37.47%
Cash/sh	9.86	P/C	5.17	EPS next 5Y	-	ROE	12.81%	52W Range	34.48 - 53.58	Perf YTD	7.78%
Dividend Est.	-	P/FCF	20.22	EPS past 5Y	-	ROI	8.35%	52W High	-4.89%	Beta	-
Dividend TTM	-	Quick Ratio	2.87	Sales past 5Y	5.48%	Gross Margin	26.23%	52W Low	47.80%	ATR (14)	1.31
Dividend Ex-Date	-	Current Ratio	2.87	EPS Y/Y TTM	-94.69%	Oper. Margin	21.30%	RSI (14)	55.94	Volatility	2.96% 2.70%
Employees	2500	Debt/Eq	0.21	Sales Y/Y TTM	39.85%	Profit Margin	19.97%	Recom	1.30	Target Price	60.55
Option/Short	Yes / Yes	LT Debt/Eq	0.20	EPS Q/Q	-80.20%	Payout	0.00%	Rel Volume	0.13	Prev Close	51.04
Sales Surprise	3.63%	EPS Surprise	33.48%	Sales Q/Q	78.95%	Earnings	May 14 AMC	Avg Volume	679.28K	Price	50.96
SMA20	1.39%	SMA50	3.69%	SMA200	11.59%	Trades		Volume	6,170	Change	-0.16%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-06-23	Initiated	Stifel	Buy	$72
Jul-05-23	Initiated	Citigroup	Neutral	$48.10
Mar-17-23	Initiated	BTIG Research	Buy	$50
Jan-18-23	Initiated	BWS Financial	Buy	$50

May-07-24 05:00PM	Seadrill Announces Two New Drillship Commitments (Business Wire)
Apr-23-24 04:30PM	Seadrill Announces First Quarter 2024 Earnings Release and Conference Call (Business Wire)
Mar-27-24 06:12AM	Seadrill Limited Files its 2023 Annual Report on Form 20-F (Business Wire)
Mar-01-24 08:52AM	Seadrill Limited (NYSE:SDRL) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-28-24 05:15PM	Seadrill Announces Fourth Quarter and Full Year 2023 Results (Business Wire)
02:30AM	Loading…
Feb-05-24 02:30AM	Seadrill Announces Fourth Quarter and Full Year 2023 Earnings Release and Conference Call (Business Wire)
Feb-02-24 08:36AM	Seadrill (SDRL) Secures New Contracts Worth $97.5 Million (Zacks)
Jan-30-24 11:50PM	Do You Think Limited Supply and Increasing Demand Favor Seadrill Limited (SDRL)? (Insider Monkey)
Jan-29-24 04:20PM	Seadrill Provides Commercial Updates on West Vela, West Capella, and West Auriga (Business Wire)
Jan-23-24 11:18AM	Seadrill 2024 Annual General Meeting of Shareholders (Business Wire)
Dec-22-23 11:17AM	Seadrill Announces Contracts for West Auriga and West Polaris in Brazil (Business Wire)
Dec-20-23 01:38AM	5 High Growth Energy Stocks to Buy (Insider Monkey)
Dec-14-23 11:47AM	Seadrill Limited Announces Organizational Change (Business Wire) +7.10%
02:16AM	Seadrill Limited Initiates New Share Buy-back Program (Business Wire)
Dec-01-23 08:06AM	Seadrill Limited (NYSE:SDRL) Q3 2023 Earnings Call Transcript (Insider Monkey)
05:26PM	Loading…
Nov-27-23 05:26PM	Seadrill Announces Third Quarter 2023 Results and Additional $250 Million Share Repurchase Authorization (Business Wire)
02:00AM	Horizonte Minerals PLC Announces BOARD AND MANAGEMENT CHANGES (ACCESSWIRE)
Nov-17-23 12:10PM	Seadrill Limited Results of the 2023 Annual General Meeting of Shareholders (Business Wire)
Oct-24-23 02:12PM	Seadrill Announces Third Quarter 2023 Earnings Release and Conference Call (Business Wire)
Sep-27-23 11:19AM	Seadrill Announces Approval of Restated Management Incentive Plan and New Incentive Awards (Business Wire)
Sep-21-23 05:15PM	Seadrill Announces Update to 2023 Annual General Meeting of Shareholders (Business Wire)
Sep-12-23 03:11AM	Seadrill Limited Initiates Previously Announced Share Repurchase Program (PR Newswire)
Aug-25-23 06:19AM	Seadrill 2023 Annual General Meeting of Shareholders (PR Newswire)
Aug-15-23 02:29AM	Seadrill Announces Second Quarter 2023 Results and $250 Million Share Repurchase Authorization (PR Newswire)
Jul-27-23 09:44AM	Seadrill Limited (SDRL) Announces Closing of $500 Million Senior Secured Second Lien Notes and Concurrent Availability of New Revolving Credit Facility (PR Newswire)
Jul-25-23 01:27PM	Seadrill Limited (SDRL) Announces Pricing of Additional $75 Million 144A / Reg S Offering of 8.375% Senior Secured Second Lien Notes Due 2030 (PR Newswire)
08:42AM	Seadrill Limited (SDRL) Announces Offering of Additional $75 Million 8.375% Senior Secured Second Lien Notes Due 2030 (PR Newswire)
Jul-20-23 01:14AM	Seadrill Limited Announces Second Quarter 2023 Earnings Release Date (PR Newswire)
Jul-13-23 11:08PM	Seadrill Limited (SDRL) Announces Pricing of $500 Million Upsized 144A / Reg S Offering of 8.375% Senior Secured Second Lien Notes Due 2030 (PR Newswire)
Jul-11-23 09:05AM	Seadrill Limited (SDRL) Provides Further Information Regarding New Revolving Credit Facility and Certain Other Information Regarding Offering of Senior Secured Second Lien Notes (PR Newswire)
08:48AM	Loading…
08:48AM	Seadrill Limited (SDRL) Announces Offering of $450 Million Senior Secured Second Lien Notes and Concurrent Entry into New Revolving Credit Facility (PR Newswire)
Jul-06-23 07:00AM	Bunker Hill Announces Appointment of Paul Smith as Director and Chair of Its New Growth Committee (GlobeNewswire)
Jun-26-23 01:42AM	Seadrill Limited (SDRL) Announces Potential Sale of Qatar Jack-Up Fleet (PR Newswire)
01:27AM	Seadrill Limited (SDRL) Investor Presentation (PR Newswire)
Jun-21-23 10:33AM	Seadrill Limited (SRDL) - Filing of Form 6-K report with unaudited financial statements for Aquadrill and unaudited pro forma financial information for Seadrill (PR Newswire)
May-23-23 01:29AM	Seadrill Limited (SDRL) - First Quarter 2023 (PR Newswire)
May-11-23 06:46PM	Seadrill Limited (SDRL) Provides Notice of 1Q23 Earnings Release and Presentation (PR Newswire)
Apr-21-23 01:10PM	Seadrill Limited - Award under Management Incentive Plan (PR Newswire)
Apr-05-23 01:47AM	Seadrill Limited (SDRL) - Fourth Quarter 2022 (PR Newswire)
Apr-03-23 06:17PM	Seadrill completes Aquadrill LLC acquisition (PR Newswire)
Mar-31-23 06:20PM	Seadrill Limited - Publication of Exempted Document in relation to the proposed Aquadrill LLC acquisition (PR Newswire)
Mar-30-23 01:28AM	Seadrill announces Notice of 4Q22 Earnings Release and Presentation (PR Newswire)
Mar-22-23 12:02AM	Seadrill Limited - Results of the 2022 Annual General Meeting of Shareholders (PR Newswire)
Mar-13-23 02:25AM	Seadrill Limited - Letter to Shareholders (PR Newswire) -5.35%
Mar-07-23 09:51PM	Seadrill announces West Neptune extension (PR Newswire)
Feb-28-23 01:14AM	Seadrill provides update on proposed Aquadrill LLC acquisition (PR Newswire)
Feb-17-23 01:34AM	SDRL - Notice of 2022 Annual General Meeting (PR Newswire)
Jan-25-23 04:46AM	SDRL - Change to Board of Directors (PR Newswire)
Dec-27-22 01:11AM	SDRL: 2022 Annual General Meeting of Shareholders (PR Newswire)
Dec-22-22 10:01PM	Seadrill Limited Announces Agreement to Acquire Aquadrill LLC in All-Stock Transaction (PR Newswire)
Nov-30-22 01:31AM	Seadrill Limited (SDRL) - Third Quarter 2022 Results (PR Newswire)
Nov-17-22 01:23AM	Seadrill Limited commences trading on the Oslo Stock Exchange (PR Newswire)
Nov-16-22 05:52AM	Seadrill Limited announces approval and publication of a prospectus supplement, and admission to trading on the Oslo Stock Exchange (PR Newswire)
Nov-03-22 02:16AM	Seadrill Limited Announces New Contract in Angola for Seadrill Joint Venture (PR Newswire)
Nov-01-22 02:24AM	Seadrill announces Notice of 3Q22 Earnings Release and Presentation (PR Newswire) +5.94%

Seadrill Ltd. engages in the provision of offshore drilling services. It owns and operates drillships, semi-submersibles and jack-ups. It operates through the following segments: Harsh Environment, Floaters, and Jack-Up Rigs. The Harsh Environment segment operates both semi-submersibles and jack-ups that have a number of design modifications to be able to handle harsh weather conditions. The Floaters segment encompasses its drillships and benign environment semi-submersible rigs. The Jack-Up Rigs segment operates mobile, self-elevating drilling platforms equipped with legs that are lowered to the seabed. The company was founded on May 10, 2005 and is headquartered in Hamilton, Bermuda.

affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings

ADPT

Adaptive Biotechnologies Corp

SDRL

Seadrill Ltd.

Upgrade your FINVIZ experience